The 9th International Symposium on DOsimetry and MOlecular Radiotherapy (Do.MoRe) will take place during the 31st Annual Congress of the European Association of Nuclear Medicine in Düsseldorf, Germany, October 13–17, 2018.
The format of the dosimetry and therapy meeting has evolved from a series of interesting and important radiopharmaceutical and dosimetry symposia held approximately every 5 years since 1970. This series was continued at the EANM Congress 2004 (Helsinki) and the SNM Congress 2009 (Toronto). These symposia were formerly known as ISTARD: “International Symposium on Targeted Radiotherapy and Radiopharmaceutical Dosimetry”. Since 2015 the symposia have been organised annually in parallel with the EANM Congress and the name has been changed to Do.MoRe, emphasising both the importance of dosimetry and the more regular organisation.
As a separate track within the EANM Congress, Do.MoRe will aim to bring together all disciplines concerned with radiopharmaceutical dosimetry, physics, radiobiology and molecular radiotherapy, stimulating interdisciplinary scientific discussion. Dosimetry is acquiring a more prominent role with respect to not only nuclear medicine therapy but also radiation protection in nuclear medicine procedures. This is reflected in this year’s EANM programme, which features a plenary lecture on “To do, or not to do dosimetry? That is the question.”
As a prelude to Do.MoRe, a pre-symposium is being organised on radiomics, artificial intelligence and machine learning techniques in hybrid imaging. Another pre-symposium will present and discuss the methods and value of dosimetry in thyroid cancer therapy. Within the framework of Do.MoRe, several symposia will be organised, one of which will outline the latest ideas from the ICRP and ICRU on treatment planning options for radionuclide therapies.
The EANM Dosimetry, Radiation Protection, Physics and Thyroid Committees will coordinate the scientific programme for the meeting jointly. All organisational matters will be handled by the EANM Executive Office.
A call for abstracts will go out in the coming months. The deadline for abstract submission is April 25, and authors will be notified about abstract acceptance on June 19, 2018.
We look forward to welcoming you in Düsseldorf in October 2018!